Identification of costimulatory molecule signatures for evaluating prognostic risk in non-small cell lung cancer
Background: Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality worldwide. Despite advances in treatment, prognosis remains poor, necessitating the identification of reliable prognostic biomarkers. Costimulatory molecules (CMs) have shown to enhance antitumor immune res...
| 出版年: | Heliyon |
|---|---|
| 主要な著者: | , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Elsevier
2024-09-01
|
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2405844024128472 |